Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Soper

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
American Journal of Obstetrics and Gynecology|June 1, 1997
Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancerS L Clifford, C P Kaminetsky, F D Cirisano, et al.
Gynecologic Oncology|October 1, 1995
Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinomaA Berchuck, C Anspach, A C Evans, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Epidermal growth factor receptor expression in normal and malignant endometriumA Berchuck, A P Soisson, G J Olt, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levelsA P Soisson, A Berchuck, B A Lessey, et al.
American Journal of Obstetrics and Gynecology|July 1, 1987
Histologic composition of endometrial carcinomas analyzed for steroid receptor contentJ T Soper, E B Cox, D Budwit-Novotny, et al.
Obstetrics and Gynecology|September 1, 1986
Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic diseaseD G Mutch, J T Soper, M E Baker, et al.
Gynecologic Oncology|November 7, 2000
A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group StudyG Sutton, V L Brunetto, L Kilgore, et al.
American Journal of Obstetrics and Gynecology|October 1, 1987
Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methodsD G Mutch, J T Soper, D A Budwit-Novotny, et al.
Radiology|January 1, 1995
Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imagingT M Weber, H D Sostman, C E Spritzer, et al.
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Obstetrics and Gynecology|June 1, 1997
Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancerS L Clifford, C P Kaminetsky, F D Cirisano, et al.
Gynecologic Oncology|October 1, 1995
Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinomaA Berchuck, C Anspach, A C Evans, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Epidermal growth factor receptor expression in normal and malignant endometriumA Berchuck, A P Soisson, G J Olt, et al.
American Journal of Obstetrics and Gynecology|November 1, 1989
Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levelsA P Soisson, A Berchuck, B A Lessey, et al.
American Journal of Obstetrics and Gynecology|July 1, 1987
Histologic composition of endometrial carcinomas analyzed for steroid receptor contentJ T Soper, E B Cox, D Budwit-Novotny, et al.
Obstetrics and Gynecology|September 1, 1986
Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic diseaseD G Mutch, J T Soper, M E Baker, et al.
Gynecologic Oncology|November 7, 2000
A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group StudyG Sutton, V L Brunetto, L Kilgore, et al.
American Journal of Obstetrics and Gynecology|October 1, 1987
Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methodsD G Mutch, J T Soper, D A Budwit-Novotny, et al.
Radiology|January 1, 1995
Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imagingT M Weber, H D Sostman, C E Spritzer, et al.
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Pageof 13